11q Deletion (del11q) Is Not a Prognostic Factor for Adverse Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Ibrutinib: Pooled Data from 3 Randomized Phase 3 Studies Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kipps, Thomas J
  • Hillmen, Peter
  • Demirkan, Fatih
  • Grosicki, Sebastian
  • Coutre, Steven E
  • Barrientos, Jacqueline C
  • Barr, Paul M
  • Janssens, Ann
  • Byrd, John C
  • O'Brien, Susan M
  • Fraser, Graeme
  • Jaeger, Ulrich
  • Cramer, Paula
  • Stilgenbauer, Stephan
  • Chanan-Khan, Asher A
  • Salman, Mariya
  • Solman, Isabelle
  • Cheng, Mei
  • Phelps, Charles
  • Ninomoto, Joi
  • Howes, Angela
  • James, Danelle F
  • Hallek, Michael

publication date

  • December 2, 2016

published in